What happened
Assort Health raised a $120 million Series C led by Menlo Ventures at a $1.2 billion valuation, reaching unicorn status and bringing total funding past $222 million. Investors include Lightspeed, Felicis, First Round, and Joe Montana.
The company builds AI agents across the patient journey, from scheduling and intake to referrals, refills, payments, and staff copilots. It has supported more than 190 million patient interactions, built on 62,000 care protocols, and revenue grew twentyfold in the prior 15 months.
Why it matters
Healthcare administration is a large, repetitive workload where staffing is chronically strained, making it a natural target for agents. The scale of interactions here suggests real deployment, not pilots.
It is also part of a broader funding wave for production AI in regulated workflows, where accuracy and auditability matter more than raw model capability.
MintedBrain take
Regulated settings raise the bar on error handling and traceability. Buyers evaluating agents for the patient journey should scrutinize how the system escalates edge cases and documents its actions, not just its headline interaction volume.
Discussion
Sign in to comment. Your account must be at least 1 day old.